human plasma proteins
ItalyDrugs containing this active substance
-
It is used to treat complex coagulation factor deficiencies (caused, for example, by severe liver damage or massive transfusions), to rapidly reverse the effect of certain oral anticoagulants in emergencies, for patients undergoing plasmapheresis, for thrombotic thrombocytopenic purpura (TTP), and for internal bleeding following plasma exchanges.
Form: solution for infusion
Active substance Dosage human plasma proteins - ATC: B05AA02
Manufacturer: OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESELLSCHAFT M.B.H.
-
It is used to treat coagulation factor deficiencies (such as in consumption coagulopathies, severe hepatic impairment, or after massive transfusions), as emergency replacement therapy when specific concentrates are unavailable, to resolve fibrinolytic activity or the effect of certain oral anticoagulants, and for the management of Thrombotic Thrombocytopenic Purpura (TTP).
Form: solution for infusion
Active substance Dosage human plasma proteins - ATC: B05AA02
Manufacturer: KEDRION S.P.A.
-
It is used to treat coagulation factor deficiencies (such as in consumption coagulopathies, severe hepatic impairment, or after massive transfusions), as emergency replacement therapy when specific concentrates are unavailable, to resolve fibrinolytic activity or the effect of certain oral anticoagulants, and for the management of Thrombotic Thrombocytopenic Purpura (TTP).
Form: solution for infusion
Active substance Dosage human plasma proteins - ATC: B05AA02
Manufacturer: KEDRION S.P.A.